Article info
PDFCurrent controversy
Vaccine passports and health disparities: a perilous journey
- Correspondence to Dr Nancy S Jecker, Department of Bioethics & Humanities, University of Washington School of Medicine, Seattle, WA 98195, USA; nsjecker{at}uw.edu
Citation
Vaccine passports and health disparities: a perilous journey
Publication history
- Received April 10, 2021
- Accepted June 22, 2021
- First published July 9, 2021.
Online issue publication
May 19, 2023
Article Versions
- Previous version (28 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- A pragmatic approach to COVID-19 vaccine passport
- Covid-19 vaccine passports: access, equity, and ethics
- Mere rhetoric? Using solidarity as a moral guide for deliberations on border closures, border reopenings and travel restrictions in the age of COVID-19
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
- ‘Learn from the lessons and don’t forget them’: identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns
- The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good
- Considerations for vaccinating children against COVID-19
- Why ‘one size fits all’ is not enough when designing COVID-19 immunity certificates for domestic use: a UK-wide cross-sectional online survey
- Three for me and none for you? An ethical argument for delaying COVID-19 boosters
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine